Bluejay Diagnostics (BJDX) Other Accumulated Expenses (2020 - 2026)

Bluejay Diagnostics (BJDX) has 6 years of Other Accumulated Expenses data on file, last reported at $104829.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses rose 0.61% year-over-year to $104829.0; the trailing twelve-month figure through Mar 2026 stood at $104829.0 (up 0.61% YoY), and the FY2025 full-year result was $156567.0, up 35.58% from the prior year.
• Other Accumulated Expenses declined to $104829.0 in Q1 2026, from $156567.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $231635.0 in Q3 2024 to a low of $104194.0 in Q1 2025.
• A 4-year average of $154209.1 and a median of $156567.0 in 2025 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses decreased 25.29% in 2024 and soared 35.58% in 2025, its largest moves.
• Tracing BJDX's Other Accumulated Expenses over 4 years: stood at $154575.0 in 2023, then declined by 25.29% to $115479.0 in 2024, then jumped by 35.58% to $156567.0 in 2025, then tumbled by 33.05% to $104829.0 in 2026.
• Business Quant data shows BJDX's Other Accumulated Expenses at $104829.0 in Q1 2026, $156567.0 in Q4 2025, and $189088.0 in Q3 2025.